Erythromycin · more major-labeled pairs than Cilostazol
SPL labels Cilostazol + Erythromycin as minor; Cilostazol 7 / Erythromycin 53 in that band.
Mechanism on file: Erythromycin interferes with the way your body processes cilostazol. This leads to higher levels of cilostazol in your system.
FDA SPL severity: Minor
Cilostazol + Erythromycin · SPL mechanism field
Erythromycin interferes with the way your body processes cilostazol. This leads to higher levels of cilostazol in your system.
Minor band excerpt · Cilostazol with Erythromycin
Reduce cilostazol tablets dose ( 2.2 , 7.1 ) 7.1 Inhibitors of CYP3A4 or CYP2C19 Inhibitors of CYP3A4 Coadministration of strong (e.g., ketoconazole) and moderate (e.g., erythromycin, diltiazem and grapefruit juice) CYP3A4 inhibitors can increase exposure to cilostazol.
Cilostazol · 7 minor + 8 total pairs
- Diltiazem minor
- Itraconazole minor
- Ketoconazole minor
- Nirmatrelvir/Ritonavir minor
Erythromycin · 4 major-labeled pairs (vs Cilostazol's 0)
- Acetaminophen/Oxycodone minor
- Alprazolam minor
- Atorvastatin minor
- Bromocriptine minor
FDA Drug Labels (SPL) via openFDA. Registry display only. Not medical advice.
Read our methodology - how this data is sourced, computed, and verified.